Blog

Anna Bruynzeel: Recap of a successful year with MRIgRT at Amsterdam UMC

Anna Bruynzeel/amsterdamumc.org

Jan 4, 2025, 09:11

Anna Bruynzeel: Recap of a successful year with MRIgRT at Amsterdam UMC

Anna Bruynzeel, Radiation Oncologist at Amsterdam UMC, shared a post on LinkedIn:

“Recap of a successful year with MRIgRT at Amsterdam UMC.

Together with our fantastic MRIdian team, a reflection on some of highlights of 2024:

10,000th Online Adaptive Fraction Delivered!
In June, this remarkable milestone was reached on the MRIdian platform.
Increase in Referrals for MRIgRT Treatments
An increasing number of patients are being referred for MRIgRT, reflecting growing recognition of the impact of MRIgRT in radiation oncology.
Launch of Four New Studies

Thanks to KWF funding, four studies were initiated:

STRONG II – For patients with perihilar cholangiocarcinoma
LAPSTAR – Focused on locally advanced pancreatic cancer
PREOPANC-5 – For borderline pancreatic cancer patients
ABLATIVE II – single ablative dose preoperative PBI in breast cancer patients

RTT-Only Treatments

This year, our radiotherapists independently treated prostate and hashtag#pancreaticcancer patients—a significant step in expanding their expertise and impact on patient care.

Improved Outcomes for Prostate Patients.

Using MRIgRT in just 5 fractions, we treated prostate cancer patients with reduced toxicity, achieving excellent outcomes with an average treatment time of only 25 minutes per session.

Innovative Care: Single-Day Plan-and-Treat.

We successfully treated kidney and lung cancer patients with a ‘single-day plan-and-treat’ process, enhancing efficiency and providing faster care for patients.

Thanks to Our Patients and Referrers for their confidence in us.”

More posts featuring Anna Bruynzeel.